ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Moderna grabs $125M in expanded Merck cancer vaccine collaboration
fiercebiotech
May 07, 2018On the heels of a massive $500 million round, Moderna has picked up another $125 million in preferred equity as it expands its mRNA cancer vaccine partnership with Merck. -
Study Reveals Huge Potential for mRNA Drug Targets
biospace
March 20, 2018Companies that have a strong focus on developing drugs that target messenger RNA (mRNA) may be ahead of the curve when it comes to potentially tapping into a lucrative market space. -
With Merck Footing the $200M Bill, Moderna Launches mRNA Cancer Vaccine Clinical Trial
biospace
November 17, 2017Moderna Therapeutics?announced?that it has dosed its first patient in a Phase I trial of mRNA-4157, a messenger RNA (mRNA)-based personalized cancer vaccine. -
Lilly, CureVac pen $1.8B mRNA cancer vaccine deal
fiercebiotech
October 19, 2017Lilly is making a $50 million upfront payment and €45 million equity investment to get the deal up and running. -
AstraZeneca strikes mRNA-based partnership in respiratory disease
pharmatimes
August 23, 2017AstraZeneca and MedImmune, the company’s biologics research arm, have forged a five year research partnership with mRNA-based pulmonary disease specialist Ethris to leverage the latter’s proprietary SNIM RNA technology in the...
Pharma Sources Insight July 2025
